A gyomorrák kezelésének aktualitásai. II. rész. A gyógyszeres kezelés patológiai alapjai és háttere, minoségbiztosítás a patológiában

Translated title of the contribution: Pathology background of targeted therapy; quality control in pathology

Research output: Contribution to journalArticle

Abstract

The administration of targeted therapy of gastric carcinoma is a very important recent improvement of its treatment and prognosis. The basis of the successful treatment is the excellent quality of pathology, now including HER2 testing: the use of validated methods and strict criteria. This is especially important if we consider that many gastric cancers are diagnosed in small biopsy material, in which HER2 testing is challenging. This requires standardized, validated methods and experienced pathologists. Being of diagnostic and predictive significance, high quality of both the technique and the interpretation of the test is mandatory. In order to achieve general high quality in this field, technical and interpretation external quality control of HER2 testing is necessary. Hungarian pathologists with the help of Roche Hungary Ltd. completed an external quality control round which showed that most of the participating laboratories are able.

Original languageHungarian
Pages (from-to)343-350
Number of pages8
JournalMagyar onkologia
Volume54
Issue number4
DOIs
Publication statusPublished - Dec 1 2010

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this